Pires, Frederico Ribeiro; Delgado, Artur Figueiredo 
; Campos, Edvaldo Vieira de; Silva, Cristina Carvalho da; Fedeli, Juliana Gadelha; Duarte, Nilo José Coelho; Kupa, Leonard de Vinci Kanda; Matsuno, Victor Kaneko; Messiano, Claudia Garcia; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Fonte: Critical Care. Nome do evento: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FCF, FM
Assuntos: FARMACOCINÉTICA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Frederico Ribeiro et al. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 01 nov. 2024. , 2019APA
Pires, F. R., Delgado, A. F., Campos, E. V. de, Silva, C. C. da, Fedeli, J. G., Duarte, N. J. C., et al. (2019). Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9NLM
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s13054-019-2503-9Vancouver
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
